CD4 and renal carcinoma: Helenalin has been reported to cause apoptosis in various cells including renal carcinoma cells [17], CD4+ T cells [55] and leukaemia cells [19], and to trigger necrosis in apoptosis-resistant cells such as Bcl-2 overexpressing leukaemia cells [46].